135 related articles for article (PubMed ID: 21205251)
1. Thromboembolic risk management in paroxysmal atrial fibrillation after brain haemorrhage.
Sanna T; Di Lazzaro V
Int J Stroke; 2011 Feb; 6(1):92-3. PubMed ID: 21205251
[No Abstract] [Full Text] [Related]
2. Clinical impact and therapeutic implications of cerebral microbleeds in patients on warfarin.
Ding D
Clin Neurol Neurosurg; 2013 Dec; 115(12):2553-4. PubMed ID: 24139629
[No Abstract] [Full Text] [Related]
3. Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?
Paciaroni M; Agnelli G
Thromb Haemost; 2014 Jan; 111(1):14-8. PubMed ID: 24258528
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
Shroff GR; Solid CA; Herzog CA
JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
[No Abstract] [Full Text] [Related]
5. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
6. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
Hu D; Sun Y
J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
[No Abstract] [Full Text] [Related]
7. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
[TBL] [Abstract][Full Text] [Related]
8. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
9. Prevention of thromboembolic events in atrial fibrillation.
Koefoed BG; Gulløv AL; Petersen P
Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
[TBL] [Abstract][Full Text] [Related]
10. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
11. Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.
Lip GY
Europace; 2011 Feb; 13(2):145-8. PubMed ID: 21138929
[No Abstract] [Full Text] [Related]
12. Thromboembolism in atrial fibrillation.
Menke J; Lüthje L; Kastrup A; Larsen J
Am J Cardiol; 2010 Feb; 105(4):502-10. PubMed ID: 20152245
[TBL] [Abstract][Full Text] [Related]
13. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Blich M; Gross B
Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
[TBL] [Abstract][Full Text] [Related]
14. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Selçuk H; Selçuk MT; Maden O
Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
[TBL] [Abstract][Full Text] [Related]
15. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Prisco D
Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
[No Abstract] [Full Text] [Related]
17. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
Cowan A; Hylek EM
J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
[No Abstract] [Full Text] [Related]
18. [Thromboembolism in non-rheumatic atrial fibrillation].
Pengo V
Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
[No Abstract] [Full Text] [Related]
19. Thrombolysis in ischemic stroke patients with prior subtherapeutic warfarin use.
Tai ML; Sharma VK
J Neurol Sci; 2011 Jan; 300(1-2):194-5; author reply 195-6. PubMed ID: 21084101
[No Abstract] [Full Text] [Related]
20. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
Garwood CL; Corbett TL
Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
